Silence Therapeutics | SLN - Equity Capital And Reserves

Stock Price
4.85
Daily Change
0.33 7.30%
Monthly
-15.36%
Yearly
-15.65%
Q1 Forecast
4.72

Silence Therapeutics reported $74.06M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AstraZeneca USD 45.89B 1.17B Sep/2025
Autolus Therapeutics Ltd USD 265.45M 81.01M Sep/2025
Hikma Pharmaceutical USD 2.55B 230M Jun/2025
Novartis USD 44.75B 2.7B Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
Silence Therapeutics USD 74.06M 20.09M Sep/2025